Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience (RGC)
NASDAQ:RGC
| Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -745.59K | $ -769.69K | $ -604.40K | $ -26.46K | - |
| Operating Income | $ -4.74M | $ -6.27M | $ -7.62M | $ -1.38M | $ -812.37K |
| EBITDA | $ -3.62M | $ -5.29M | $ -6.99M | $ -1.35M | $ -802.86K |
| Net Income | $ -4.30M | $ -5.87M | $ -7.42M | $ -1.35M | $ -812.37K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.96M | $ 11.56M | $ 16.42M | $ 59.41K | $ 386.98K |
| Total Assets | $ 8.44M | $ 12.62M | $ 18.02M | $ 340.13K | $ 514.02K |
| Total Debt | $ 85.74K | $ 463.67K | $ 771.25K | $ 3.68M | $ 3.07M |
| Net Debt | $ -2.88M | $ -1.10M | $ -5.65M | $ 3.62M | $ 2.68M |
| Total Liabilities | $ 219.51K | $ 632.32K | $ 938.03K | $ 4.34M | $ 3.16M |
| Stockholders' Equity | $ 8.22M | $ 12.03M | $ 17.07M | $ -4.00M | $ -2.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.01M | $ -4.99M | $ -6.05M | $ -767.31K | $ -844.41K |
| Operating Cash Flow | $ -4.00M | $ -4.96M | $ -5.27M | $ -767.31K | $ -726.57K |
| Investing Cash Flow | $ 5.24M | $ 58.98K | $ -10.78M | $ 0.00 | $ -117.84K |
| Financing Cash Flow | $ 102.28K | $ 134.91K | $ 22.41M | $ 439.75K | $ 988.08K |
Regencell Bioscience Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.